B7-33
Also known as: B7-33, Single-chain relaxin peptide
Molecular Overview
B7-33 is a single-chain relaxin-derived peptide described in the literature as a relaxin mimetic acting at RXFP1, studied in preclinical vascular and fibrosis models.
Mechanistic Background
Engages RXFP1 signalling associated with relaxin biology in experimental models.
What Researchers Study
Preclinical research has examined vascular and anti-fibrotic endpoints.
Evidence Landscape
Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
Evidence is preclinical; findings should not be interpreted as therapeutic claims.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.